Citadel Advisors’s MorphoSys AG American Depositary Shares MOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-18,200
Closed -$331K 15629
2024
Q2
$331K Sell
18,200
-68,800
-79% -$1.25M ﹤0.01% 8936
2024
Q1
$1.58M Sell
87,000
-143,100
-62% -$2.12M ﹤0.01% 5991
2023
Q4
$2.28M Buy
230,100
+209,600
+1,022% +$1.54M ﹤0.01% 5131
2023
Q3
$138K Buy
20,500
+17,900
+688% +$138K ﹤0.01% 10485
2023
Q2
$19.4K Buy
+2,600
New +$15.8K ﹤0.01% 12749

Other funds holding MOR

Citadel Advisors's MOR Position: Q2 2024 in Review

Citadel Advisors sold out of MorphoSys AG American Depositary Shares (MOR) in Q2 2024, closing a stake of 3,594 shares — an estimated $65.3K sold.

Citadel Advisors first reported a position in MOR in Q2 2018 and held it in 16 quarters. The position peaked at $3.71M in Q2 2020. 26 funds tracked by Wall St. Rank hold MOR as of Q2 2024.

  • Citadel Advisors reported no remaining MorphoSys AG American Depositary Shares position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 3,594 MorphoSys AG American Depositary Shares shares in Q2 2024, an estimated $65.3K.
  • Citadel Advisors first reported a position in MorphoSys AG American Depositary Shares in Q2 2018 and held it in 16 quarters.
  • Citadel Advisors's MorphoSys AG American Depositary Shares position peaked at $3.71M in Q2 2020.
  • 26 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.